Efficacy and Tolerability of Nasobol, an Intra-Nasal Testosterone Product, for Testosterone Replacement in Hypogonadal Men.
Phase of Trial: Phase II
Latest Information Update: 17 Oct 2017
At a glance
- Drugs Testosterone (Primary) ; Testosterone
- Indications Hypogonadism
- Focus Pharmacokinetics
- Sponsors Acerus Pharmaceuticals
- 17 Oct 2017 Trimel Pharmaceuticals Corporation changed its name to Acerus Pharmaceuticals Corporation in Sep 2015.
- 05 Aug 2011 Trial results met the FDA's guidelines for product approval, according to a Trimel Pharmaceuticals media release.
- 06 Aug 2010 Actual end date (May 2010) added as reported by ClinicalTrials.gov.